Results 291 to 300 of about 410,631 (308)

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

New England Journal of Medicine, 2012
Ronald F Van Vollenhoven, Roy Fleischmann, Eun Bong Lee   +2 more
exaly  

Rheumatoid arthritis

Postgraduate Medicine, 1975
J. Donald Smiley, Nadene Coyne
openaire   +2 more sources

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

New England Journal of Medicine, 2020
Andrea Rubbert-Roth, Jeffrey Enejosa, Aileen L Pangan   +2 more
exaly  

Rheumatoid Arthritis

2008
openaire   +3 more sources

Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications

New England Journal of Medicine, 1996
James R O'Dell, J R O'Dell, O'Dell James R   +2 more
exaly  

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

New England Journal of Medicine, 2004
Jonathan Edwards, Anna Filipowicz-Sosnowska, Paul Emery   +2 more
exaly  

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

New England Journal of Medicine, 1997
Larry W Moreland, Michael H Schiff, Roy Fleischmann   +2 more
exaly  

Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

New England Journal of Medicine, 2001
Ernest Choy, G S Panayi
exaly  

Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis

New England Journal of Medicine, 1978
Peter Stastny, P Stastny, Stastny Peter   +2 more
exaly  

STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus

New England Journal of Medicine, 2007
Elaine F Remmers, Annette T Lee, Timothy W Behrens   +2 more
exaly